ASP Isotopes Inc. (ASPI): Nasdaq/NYSE listing notice — ASP Isotopes receives Nasdaq deficiency notice for bid price below $1.00

ASP Isotopes Inc.

Letter dated May 5, 2023; stock has been below $1.00 for 30 consecutive business days.
Company has 180 days (until Nov 1, 2023) to regain compliance by closing at $1.00 for 10 consecutive days.
If not cured, may seek an additional 180-day period by transferring to Nasdaq Capital Market and possibly effecting a reverse stock split.
Common stock continues trading on Nasdaq Capital Market; no immediate effect on listing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ASP Isotopes Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5810(c)(3)(A)

Exact text from the filing

May 5, 2023, ASP Isotopes Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5810(c)(3)(A) (the “Minimum Bid Price Requirement”). The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or trading of the Company’s common s

View on SEC.gov

Browse all listing & compliance notices →

ASP Isotopes Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-003254

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.